Edition:
United States

Immune Design Corp (IMDZ.OQ)

IMDZ.OQ on NASDAQ Stock Exchange Global Market

4.30USD
20 Jul 2018
Change (% chg)

$-0.15 (-3.37%)
Prev Close
$4.45
Open
$4.45
Day's High
$4.55
Day's Low
$4.07
Volume
56,765
Avg. Vol
43,213
52-wk High
$13.00
52-wk Low
$2.80

Select another date:

Wed, May 2 2018

BRIEF-Immune Design Q1 Loss Per Share $0.28

* IMMUNE DESIGN REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

BRIEF-Immune Design Reports Q4 Loss Per Share $0.29

* IMMUNE DESIGN REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

BRIEF-Immune Design Reports Data Update For Lead Immunotherapy Programs

* IMMUNE DESIGN REPORTS DATA UPDATE FOR LEAD IMMUNOTHERAPY PROGRAMS: IMPROVEMENT IN SURVIVAL FOR CMB305 MONOTHERAPY IN SARCOMA AND INCREASED OBJECTIVE RESPONSES FOR G100/PEMBROLIZUMAB COMBINATION IN FOLLICULAR LYMPHOMA

BRIEF-Immune Design To Report Q4 And Year End 2017 Financial Results And Provide Corporate Update

* IMMUNE DESIGN TO REPORT FOURTH QUARTER AND YEAR END 2017 FINANCIAL RESULTS AND PROVIDE CORPORATE UPDATE Source text for Eikon: Further company coverage:

Select another date: